The Promise of Liquid Biopsies | Cancer Today
Blood tests that detect traces of cancer cells and tumor DNA help find residual disease after treatment is completed.
Blood tests that detect traces of cancer cells and tumor DNA help find residual disease after treatment is completed.
Positive high-level results from an interim analysis of the ECHO Phase III trial showed AstraZeneca’s Calquence (acalabrutinib) in combination with standard-of-care chemoimm unotherapy, bendamustine and…
The OncoAlert Newsletter is now out for June 23-29, 2023
The world’s most influential people in health have made fresh discoveries, dreamed up novel treatments, and pioneered global victories over disease.
Systemically administered mRNA aggregates (RNA-LPA) transfect lymphoreticular organs, inducing a massive cytokine/chemokine response that rapidly reprograms the tumor microenvironment while mobilizing dendritic cells/lymphocytes to elicit…
The 2024 ASCO Annual Meeting is the most significant gathering of oncology professionals worldwide, making connections and forging collaborations that can
The world’s most influential people in health have made fresh discoveries, dreamed up novel treatments, and pioneered global victories over disease.
Croatia, Workshop, Hemostasis, thrombosis, education This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others…
The OncoAlert Newsletter is now out for June 23-29, 2023
C. Ola Landgren, MD, PhD, discussed the FDA’s unanimous ODAC vote supporting minimal residual disease as an accelerated approval end point in multiple myeloma and…
Who should do an away rotation – and who should think twice? Where should you do an away rotation? Is it worth doing an away…